BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Aug. 7, 2017
View Archived Issues
Eisai reviews highlights of first quarter of fiscal 2017
Read More
Phase III study of Traumakine in ARDS recommended to continue
Read More
M Pharmaceutical USA changes name to Callitas Therapeutics
Read More
Ritter reports further analysis of phase IIb/III trial of RP-G28 for lactose intolerance
Read More
Lilly reports data from SPARTAN trial of lasmiditan for acute treatment of migraine
Read More
TCB selected to receive H2020 grant for the development of next-generation allogeneic approach
Read More
FDA grants priority review to Alecensa for first-line treatment of ALK-positive NSCLC
Read More
Mallinckrodt to acquire InfaCare along with its proprietary therapy stannsoporfin
Read More
MiMedx files to begin IND phase III trial of AmnioFix for achilles tendonitis
Read More
Ono Pharmaceutical updates milestones of first quarter of fiscal 2017
Read More
FDA issues complete response letter for CCP-08 NDA
Read More
Sanofi compound SAR-489883 targets protein kinase R for Alzheimer's disease
Read More
FDA grants orphan drug designation to OMS-721 for IgA nephropathy
Read More
UCB and Medical Research Council establish antibody discovery collaboration
Read More
HitGen and Leo Pharma establish multi-year research collaboration
Read More
Monoclonal IgM targets beta-amyloid and tau oligomers in Alzheimer's disease
Read More
The PS externalization pathway as a potential new target for the development of anti-HIV-1 therapies
Read More
New phase I trial studies MK-1092 in healthy subjects and patients with type 1 diabetes
Read More
Targeting HDAC6 as a potential new therapeutic strategy for ARID1A-mutated ovarian cancers
Read More
Biofrontera agrees to Ameluz development plan with FDA
Read More
Ningbo Wenda describes novel bromodomain-containing protein 4 inhibitors
Read More
Starpharma reports phase III results for VivaGel BV in recurrent bacterial vaginosis
Read More
Boehringer Ingelheim patents nuclear receptor RORgamma antagonists
Read More
Janssen R&D Ireland presents novel anti-influenza compounds
Read More
Prospero Pharmaceuticals divulges agents for pantothenate kinase-associated neurodegeneration
Read More
Clearance for first-in-human study of ORBCEL-M for diabetic kidney disease
Read More
Fred Hutchinson studies 211At-BC8-B10 before donor stem cell transplant in AML, ALL and MDS
Read More
EMO Biomedicine begins phase I study of RegStem for knee osteoarthritis
Read More